10
2
1
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T33891 | PBI-1393 | PBI1393,BCH1393,BCH 1393,BCH-1393,PBI 1393 | |
PBI-1393 can be used as an enhancer for Th1 type cytokine production and primary T cell activation. | |||
T28304 | PBI-51 | ||
PBI-51 is a competitive inhibitor of abscisic acid-regulated gene expression. | |||
T12883 | Fezagepras | PBI-4050,Setogepram | GPR |
Fezagepras (Setogepram) is an orally active GPR40 agonist and is an antagonist or inverse agonist of GPR84 with anti-inflammatory, anti-fibrotic, and anti-proliferative actions. | |||
T12375 | Fezagepras sodium | Setogepram sodium salt,PBI-4050 sodium salt | GPR |
Fezagepras sodium (Setogepram sodium salt) is an orally active GPR40 agonist and is an antagonist or inverse agonist for GPR84, with anti-fibrotic, anti-inflammatory and anti-proliferative actions. | |||
T74901 | PBI-6DNJ | ||
PBI-6DNJ, an orally active and potent multivalent glycosidase inhibitor, demonstrates significant inhibition activity against α-glucosidase from mice, featuring a K i value of 0.14 μM. It also exhibits notable hypoglycem... | |||
T73052 | Pomotrelvir | PBI-0451 | |
Pomotrelvir (PBI-0451) is a selective, orally administered inhibitor of the SARS-CoV-2 3CL protease, exhibiting antiviral properties suitable for research into the novel coronavirus (COVID-19). | |||
T62447 | Paltimatrectinib | PBI-200,PPI-5278 | Trk receptor , Tyrosine Kinases |
Paltimatrectinib (PBI-200) is a potent tyrosine kinase inhibitor with anticancer activity that inhibits myosin-related kinase A (TrkA).Paltimatrectinib is used in the study of bladder, breast and colorectal cancers. | |||
T16435 | PBIT | Histone Demethylase , Histone Methyltransferase | |
PBIT inhibits JARID1B histone demethylase (IC50 of about 3 μM). PBIT also inhibits JARID1A and JARID1C (IC50s of 6 μM and 4.9 μM, respectively). PBIT is a specific inhibitor of the Jumonji AT-rich Interactive Domain 1 (J... | |||
T69136 | BIPBIPU | ||
BIPBIPU is a novel heparanase inhibitor. | |||
T6939 | PFI-3 | PFI 3 | Epigenetic Reader Domain |
PFI-3 is a selective chemical inhibitor for SMARCA (2/4) (Kd = 89 nM)and PBI (5) bromodomains which may result in the delay and prevention of breast cancer. |
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T83532 | (Rac)-Dehydrovomifoliol | PBI 344 | |
(Rac)-Dehydrovomifoliol (PBI 344), a bisnorsesquiterpene, is present in Euphorbia peplus [1]. | |||
T5S0890 | Oleandrin | Neriostene,Folinerin,Foliandrin | Apoptosis , ATPase , Potassium Channel , Sodium Channel |
1. Oleandrin (Folinerin), the principal cardiac glycoside component of PBI-524, can quantitatively account for regulation of BDNF at both the protein and transcriptional levels. 2. Oleandrin are known to inhibit the Na, ... |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPH-01903 | APOBEC3C Protein, Human, Recombinant (GST) | Human | E. coli |
APOBEC3C Protein, Human, Recombinant (GST) is expressed in E. coli expression system with N-GST tag. The predicted molecular weight is 49.8 kDa and the accession number is Q9NRW3. |